Loading...

Investigational FMS-Like Tyrosine Kinase 3 (FLT3) Inhibitors in Treatment of Acute Myeloid Leukemia (AML)

INTRODUCTION: Outcomes for the majority of patients with Acute Myeloid Leukemia (AML) remain poor. Over the past decade, significant progress has been made in the understanding of the cytogenetic and molecular determinants of AML pathogenesis. One such advance is the identification of recurring muta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Pemmaraju, Naveen, Kantarjian, Hagop, Andreeff, Michael, Cortes, Jorge, Ravandi, Farhad
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109297/
https://ncbi.nlm.nih.gov/pubmed/24749672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2014.911839
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!